Piper Sandler analyst Korinne Wolfmeyer raised the firm’s price target on Hims & Hers to $13 from $11 and keeps a Neutral rating on the shares. The Hims & Hers model is proving effective, with Q1 delivering impressive subscriber growth and more efficient spending helping adjusted EBITDA percentage reach the double digits, the firm says. Nonetheless, Piper argues that if this top line momentum doesn’t hold, the margin progression is at risk. The firm says it doesn’t yet have enough color on new category performance, and still struggles to have confidence in subscriber retention and longer term customer conversion in these new and larger TAMs.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- HIMS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Hims & Hers Health Adds New Independent Director
- Hims and Hers Health call volume above normal and directionally bullish
- Hims & Hers downgraded to Hold from Buy at Jefferies
- Yum! downgraded, Cava upgraded: Wall Street’s top analyst calls